The Pit-1 transcription factor (also know as POU1F1) plays a critical role in cell differentiation during organogenesis of the anterior pituitary in mammals and is a transcriptional activator for pituitary gene transcription. Increased expression of Pit-1 has been reported in human tumorigenic breast cells. Here, we found that Pit-1 overexpression or knockdown in human breast cancer cell lines induced profound phenotypic changes in the expression of proteins involved in cell proliferation, apoptosis, and invasion. Some of these protumorigenic effects of Pit-1 were mediated by upregulation of Snai1, an inductor of the epithelial-mesenchymal transition. In immunodeficient mice, Pit-1 overexpression induced tumoral growth and promoted metastasis in lung. In patients with invasive ductal carcinoma of the breast and node-positive tumor, high expression of Pit-1 was significantly correlated with Snai1 positivity. Notably, in these patients elevated expression of Pit-1 was significantly and independently associated with the occurrence of distant metastasis. These findings suggest that Pit-1 could help to make a more accurate prognosis in patients with node-positive breast cancer and may represent a new therapeutic target.
Isabel Ben-Batalla, Samuel Seoane, Tomas Garcia-Caballero, Rosalia Gallego, Manuel Macia, Luis O. Gonzalez, Francisco Vizoso, Roman Perez-Fernandez
Title and authors | Publication | Year |
---|---|---|
Phosphatidylinositol promoted the proliferation and invasion of pituitary adenoma cells by regulating POU1F1 expression
Xu T, Zhai X, Wang R, Wu X, Zhou Z, Shang M, Wang C, Qi T, Yang W |
Cancer & Metabolism | 2025 |
Comparing 68Ga-Pentixafor,18F-FDG PET/CT and Chemokine Receptor 4 Immunohistochemistry Staining in Breast Cancer: A Prospective Cross Sectional Study
Hadebe B, Harry L, Gabela L, Nxasana T, Ndlovu N, Pillay V, Masikane S, Patel M, Mpanya D, Buccimaza I, Msimang M, Aldous C, Sathekge M, Vorster M |
Cancers | 2025 |
Expression of CXCR4 in the Primary Lesion of Recurrent Metastatic Breast Cancer and Its Association With Prognosis
Huang D, Lin D, Liang S, Lin J |
International Journal of General Medicine | 2025 |
CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications.
Yang Y, Li J, Lei W, Wang H, Ni Y, Liu Y, Yan H, Tian Y, Wang Z, Yang Z, Yang S, Yang Y, Wang Q |
International journal of biological sciences | 2023 |
Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms.
Muñoz A, Grant WB |
Nutrients | 2022 |
POU1F1 transcription factor induces metabolic reprogramming and breast cancer progression via LDHA regulation
A Martínez-Ordoñez, S Seoane, L Avila, N Eiro, M Macía, E Arias, F Pereira, T García-Caballero, N Gómez-Lado, P Aguiar, F Vizoso, R Perez-Fernandez |
Oncogene | 2021 |
HMGA1B/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12/CXCR4 axis-mediated macrophage polarization
C Tang, X Lei, L Xiong, Z Hu, B Tang |
Cell Death and Disease | 2021 |
Geometric regulation of histone state directs melanoma reprogramming
J Lee, TG Molley, CH Seward, AA Abdeen, H Zhang, X Wang, H Gandhi, JL Yang, K Gaus, KA Kilian |
2020 | |
Two machine learning methods identify a metastasis-related prognostic model that predicts overall survival in medulloblastoma patients
K Chen, B Huang, S Yan, S Xu, K Li, K Zhang, Q Wang, Z Zhuang, L Wei, Y Zhang, M Liu, H Lian, C Zhong |
Aging | 2020 |
Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis
A Martinez-Ordoñez, S Seoane, P Cabezas, N Eiro, J Sendon-Lago, M Macia, T Garcia-Caballero, LO Gonzalez, L Sanchez, F Vizoso, R Perez-Fernandez |
Oncogene | 2018 |
Joint single-cell DNA accessibility and protein epitope profiling reveals environmental regulation of epigenomic heterogeneity
X Chen, UM Litzenburger, Y Wei, AN Schep, EL LaGory, H Choudhry, AJ Giaccia, WJ Greenleaf, HY Chang |
Nature Communications | 2018 |
A novel thymoma-associated autoimmune disease: Anti-PIT-1 antibody syndrome
H Bando, G Iguchi, Y Okimura, Y Odake, K Yoshida, R Matsumoto, K Suda, H Nishizawa, H Fukuoka, A Mokubo, K Tojo, Y Maniwa, W Ogawa, Y Takahashi |
Scientific Reports | 2017 |
Vitamin D and the Epithelial to Mesenchymal Transition
MJ Larriba, AG de Herreros, A Muñoz |
Stem Cells International | 2016 |
Over-Expression of POU Class 1 Homeobox 1 Transcription Factor (Pit-1) Predicts Poor Prognosis for Breast Cancer Patients
Gao Z, Xue K, Zhang L, Wei M |
Medical science monitor : international medical journal of experimental and clinical research | 2016 |
Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment
Samuel Seoane, Efigenia Arias, Rita Sigueiro, Juan Sendon-Lago, Anxo Martinez-Ordoñez, Esteban Castelao, Noemí Eiró, Tomás Garcia-Caballero, Manuel Macia, Rafael Lopez-Lopez, Miguel Maestro, Francisco Vizoso, Antonio Mouriño, Roman Perez-Fernandez |
Oncotarget | 2015 |
A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer
N Eiró, B Fernandez-Garcia, J Vázquez, JM Casar, LO González, FJ Vizoso |
OncoImmunology | 2015 |
AGPAT9 suppresses cell growth, invasion and metastasis by counteracting acidic tumor microenvironment through KLF4/LASS2/V-ATPase signaling pathway in breast cancer
S Fan, Y Wang, Z Wu, Z Zhang, J Lu, M Li, Q Shan, D Wu, C Sun, B Hu, Y Zheng |
Oncotarget | 2015 |
Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma
JS Waizenegger, I Ben-Batalla, N Weinhold, T Meissner, M Wroblewski, M Janning, K Riecken, M Binder, D Atanackovic, H Taipaleenmaeki, D Schewe, S Sawall, V Gensch, M Cubas-Cordova, A Seckinger, W Fiedler, E Hesse, N Kröger, B Fehse, D Hose, B Klein, MS Raab, K Pantel, C Bokemeyer, S Loges |
Leukemia | 2014 |
Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13
J Sendon-Lago, S Seoane, N Eiro, MA Bermudez, M Macia, T Garcia-Caballero, FJ Vizoso, R Perez-Fernandez |
Breast Cancer Research | 2014 |
Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells.
Eiró N, Sendon-Lago J, Seoane S, Bermúdez MA, Lamelas ML, Garcia-Caballero T, Schneider J, Perez-Fernandez R, Vizoso FJ |
Oncotarget | 2014 |
POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15)
S Lisboa, N Cerveira, S Bizarro, C Correia, J Vieira, L Torres, JM Mariz, MR Teixeira |
Molecular Cancer | 2013 |
Effects on tumor development and metastatic dissemination by the NKG2D lymphocyte receptor expressed on cancer cells
A El-Gazzar, X Cai, RS Reeves, Z Dai, A Caballero-Benitez, DL McDonald, J Vazquez, TA Gooley, GE Sale, T Spies, V Groh |
Oncogene | 2013 |
26,26,26,27,27,27-Hexadeuterated-1,25-Dihydroxyvitamin D3 (1,25D-d6) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines
S Seoane, MA Bermudez, J Sendon-Lago, A Martinez-Ordoñez, S Abdul-Hadi, M Maestro, A Mouriño, R Perez-Fernandez |
Cancers | 2013 |
Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese
S Akamatsu, R Takata, CA Haiman, A Takahashi, T Inoue, M Kubo, M Furihata, N Kamatani, J Inazawa, GK Chen, LL Marchand, LN Kolonel, T Katoh, Y Yamano, M Yamakado, H Takahashi, H Yamada, S Egawa, T Fujioka, BE Henderson, T Habuchi, O Ogawa, Y Nakamura, H Nakagawa |
Nature Genetics | 2012 |
Research Resource: A Genome-Wide Study Identifies Potential New Target Genes for POU1F1
JP Herman, N Jullien, S Guillen, A Enjalbert, I Pellegrini, JL Franc |
Molecular Endocrinology | 2012 |